# Revital Healthcare receives grant to expand syringe production in Kenya

Revital Healthcare received nearly $4 million from the Bill & Melinda Gates Foundation to expand production of auto-disable vaccine syringes. The funding will increase production from 72 million to nearly 265 million syringes annually by end of 2022.

- Type: Expansion
- Announced: 2021-11-04
- Where: Mombasa, Kenya, Kenya
- Value: $4.00M
- Starts operating: 2022
- Status: announced
- Capacity: 265 million auto-disable syringes annually
- Products: auto-disable vaccine syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Revital Healthcare](https://endata.com/companies/58727.md)
- [Bill & Melinda Gates Foundation](https://endata.com/companies/58728.md) (investor)

## Sources

- [africa.com](https://africa.com/ama/kenyan-auto-disable-syringe-manufacturer-revital-healthcare-receives-grant-funding-to-ramp-up-syringe-manufacturing-to-address-looming-shortfall-in-low-and-middle-income-countries), 2021-11-04: "Revital Healthcare ... announced today it received nearly $4 million from the Bill & Melinda Gates Foundation to expand production of auto-disable vaccine syringes."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.